GrowthCurve Capital buys treatment entry co TailorMed

Israeli treatment entry firm TailorMed has introduced a majority funding by GrowthCurve Capital personal fairness fund. The acquisition of the bulk stake is at an estimated firm valuation of $250 million and represents an exit for many of the firm’s traders.

TailorMed will proceed to function beneath the fund with its present administration workforce. It is going to preserve its growth heart in Tel Aviv, which has about 60 workers, practically half the corporate’s workforce of 130. With the fund’s assist, TailorMed will pursue acquisitions and mergers with different firms in its sector.

Thus far, $60 million has been invested within the firm, that means all traders, together with a number of Israeli funds, are set to learn from the deal. The corporate grew throughout the Sanara Ventures incubator and obtained investments from TriVentures, Accelmed, Bridges, Samsung Subsequent, Low cost Capital, and the publicly traded Almeda Ventures (TASE: ALMD) R&D partnership. In response to its monetary experiences, Almeda holds a stake of about 3% within the firm, following a $2.4 million funding. Different traders embody the Windfall hospital community, Citibank, the American Most cancers Society, and US-based Windham Capital Companions, amongst others. The corporate additionally secured debt financing from Financial institution Hapoalim.

TailorMed was based in 2016 by CEO Srulik Dvorsky, previously VP of R&D at medical system firm Brainsgate, and CTO Adam Siton, who beforehand headed the cellular division at Any.do.

The corporate has developed a platform that identifies treatment help packages for sufferers. Within the US, out-of-pocket prices for medicines and medical therapies are excessive, and never all sufferers are in a position to handle them. Discovering monetary help is within the curiosity of a number of stakeholders throughout the system: the affected person, in fact, but additionally the hospital, which can wrestle to gather excellent money owed from sufferers, and pharmaceutical firms. For the latter, it’s typically advantageous to cowl a affected person’s out-of-pocket prices to safe a bigger cost from the insurance coverage firm. The platform due to this fact connects sufferers with such assist packages.

“Following a household expertise with most cancers”

You managed to construct an organization that developed a exact resolution for the US healthcare system, regardless of having no prior expertise working in a US hospital or a US insurance coverage firm. How did you provide you with this concept, and the way did you go about studying the market?

Dvorsky: “In a approach, what occurred to us wasn’t presupposed to occur. I’m unsure how the playing cards fell into place. The will to unravel an issue within the healthcare sector stemmed from coping with most cancers inside my household. I knew I used to be concentrating on the US market, and I approached it not by being wedded to a particular thought, however slightly with the intent to pay attention. I knew I did not need to spend years constructing know-how solely to come across the market afterward. As an alternative, I needed to construct one thing, even when small, which was really helpful, and instantly hit the bottom working to have interaction with the market firsthand.”

The primary platform was applied in 2018. As soon as the corporate demonstrated that the hospital might recoup its funding by decreasing unhealthy debt, the trail opened up for additional development. At present, platforms are deployed in roughly 950 hospitals and 4,700 clinics, and the corporate works with over 3,000 pharmacies, together with the Walgreens chain. It connects enrolled sufferers to about 6,000 totally different assist packages, 100 of that are sponsored by pharmaceutical firms. By its personal estimates, the corporate has facilitated $7.4 billion in monetary help for 75 million sufferers.

Since then, the corporate has expanded into different areas involving the connection between sufferers and pharmaceutical companies. Dvorsky explains, “Within the US, pharmaceutical firms are prohibited from reaching out on to sufferers, so that they started asking us to tackle further duties. For example, Eli Lilly requested that sufferers with a prescription for considered one of their medicines obtain steerage on managing potential unwanted side effects. In addition they requested that, at some point previous to an appointment, sufferers obtain info on how one can put together for receiving the treatment.”

4 years in the past, Dvorsky moved to the US to handle the corporate.

After all of your work throughout the healthcare system, was there something that stunned you as a affected person?

“My very own experiences as a shopper really confirmed what we already knew. After I spent an evening in a hospital and subsequently obtained a prescription, no info concerning monetary help was supplied to me, neither by the hospital nor by the pharmacy chain Walgreens (which is now a consumer of ours and does supply such info).

“Different Israelis dwelling within the US are sometimes fairly shocked by the system. The invoice is introduced solely after therapy is full, and the overall could be shockingly excessive, which creates a way of concern surrounding any medical care. I spend fairly a number of Sundays explaining insurance policy to my buddies.”

“Our key differentiator is the community impact.”

The corporate is presently creating an AI product that autonomously consolidates all related knowledge. “Our aim is to shift to a mannequin the place the AI manages the method, reaching out to a human brokers solely when it hits a roadblock, slightly than the opposite approach round.”

Nevertheless, he stresses, “Our true differentiator is not the AI or the information itself, however slightly the community impact. Since all these stakeholders are already registered on our platform, the worth of becoming a member of will increase for each new participant. This additionally creates a barrier to entry for rivals – one which even AI is unlikely to beat. GrowthCurve Capital focuses on firms that leverage community results and in scaling them additional.”

Robert Thwaites, a Director at GrowthCurve, added, “TailorMed represents the most important, most in depth, and most various community within the affected person monetary help house, built-in throughout healthcare suppliers. They’re exceptionally well-positioned to proceed eradicating limitations to medical look after tens of millions of sufferers within the US.”

Revealed by Globes, Israel enterprise information – en.globes.co.il – on November 2, 2026.